Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sales growth lifts CR Bard's 4Q profit
Yahoo/AP
Friday, February 1, 2013 - 11:41am
tags:
earnings, CR Bard, devices
Isis: FDA Approval Of Kynamro Promises A Bright Future For Company
Seeking Alpha
Friday, February 1, 2013 - 11:40am
tags:
FDA, Kynamro, Isis Pharmaceuticals, Sanofi, Genzyme, Homozygous Familial Hypercholesterolemia
Vivus Stock Up On Qsymia Heart Disease Study
Investors.com
Friday, February 1, 2013 - 11:38am
tags:
Vivus, Qsymia
Insight: Revived search for a TB vaccine may be about to pay off
Reuters
Friday, February 1, 2013 - 11:37am
tags:
tuberculosis, vaccines, Aeras, MVA85A
Medicare to adjust payment for dialysis drugs after overspending millions
Washington Post, DC
Friday, February 1, 2013 - 11:34am
tags:
Medicare, dialysis
Pfizer, Zoloft And The Vexing Placebo Effect
Pharmalot
Friday, February 1, 2013 - 11:33am
tags:
Pfizer, Zoloft, placebo effect, antidepressants
Spectrum Pharma's Bladder Cancer Bamboozle
TheStreet.com
Friday, February 1, 2013 - 11:32am
tags:
Spectrum Pharmaceuticals, bladder cancer, apaziquone, Allergan
Allergan Fourth Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Friday, February 1, 2013 - 11:30am
tags:
earnings, Allergan
Amarin announces notification of additional U.S. patent allowance
The Fly on the Wall
Friday, February 1, 2013 - 11:29am
tags:
Amarin, Vascepa
Two Biotech Names Without the Microcap Roller Coaster
Motley Fool
Friday, February 1, 2013 - 11:28am
tags:
Acadia, Depomed
Merck Earnings: Exceeding Estimates Not Enough to Impress
Wall St. Cheat Sheet
Friday, February 1, 2013 - 11:03am
tags:
earnings, Merck
[video] Roche's CEO on Profit Pipeline
CNBC
Friday, February 1, 2013 - 11:02am
tags:
Roche
Alkermes Turns to Profit, Ups View
Yahoo/Zacks
Friday, February 1, 2013 - 11:01am
tags:
earnings, Alkermes
Zoetis raises about $2.2 billion in IPO
Yahoo/AP
Friday, February 1, 2013 - 11:00am
tags:
Zoetis, IPO, animal health, Pfizer
AstraZeneca, Bristol-Myers’s Forxiga Not Backed by NICE
Bloomberg
Friday, February 1, 2013 - 10:57am
tags:
AstraZeneca, Forxiga, Bristol-Myers Squibb, UK, diabetes
Merck says now anticipates odanacatib filing in 2014
Yahoo/Fly on the Wall
Friday, February 1, 2013 - 10:55am
tags:
Merck, Odanacatib, osteoarthritis
Two Peas in a Pharma Pod
Motley Fool
Friday, February 1, 2013 - 10:54am
tags:
Pfizer, Bristol-Myers Squibb, earnings
Bristol-Myers seeking buyer for Mexico, Brazil brands-WSJ
Reuters
Friday, February 1, 2013 - 10:45am
tags:
Mexico, M&A, Brazil, Bristol-Myers Squibb
Sarepta Therapeutics Setting Up For Another Move Upward
Seeking Alpha
Thursday, January 31, 2013 - 10:49am
tags:
Sarepta Therapeutics, eteplirsen, Duchenne Muscular Dystrophy
ArQule enrolls first patient in Phase 3 trial for carcinoma candidate tivantinib
Yahoo/Fly on the Wall
Thursday, January 31, 2013 - 10:48am
tags:
Arqule, tivantinib, hepatocellular carcinoma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.